Health-Related Quality of Life in Patients with Oesophageal Cancer: Analysis at Different Steps of the Treatment Pathway

被引:54
作者
Scarpa, Marco [1 ]
Saadeh, Luca M. [1 ]
Fasolo, Alessandra [1 ]
Alfieri, Rita [1 ]
Cagol, Matteo [1 ]
Cavallin, Francesco [1 ]
Pinto, Eleonora [1 ]
Zaninotto, Giovanni [2 ,3 ]
Ancona, Ermanno [1 ,3 ]
Castoro, Carlo [1 ]
机构
[1] Veneto Inst Oncol IOV IRCCS, Oncol Surg Unit, I-35128 Padua, Italy
[2] S Giovanni & Paolo Hosp, Gen Surg Unit, Venice, Italy
[3] Univ Padua, Dept Surg & Gastroenterol Sci, Padua, Italy
关键词
Health-related quality of life; Oesophageal cancer; SQUAMOUS-CELL CARCINOMA; NEOADJUVANT CHEMORADIOTHERAPY; EORTC IN-PATSAT32; CONTROLLED-TRIAL; PHASE-II; SURGERY; ADENOCARCINOMA; QUESTIONNAIRE; MANAGEMENT; RESECTION;
D O I
10.1007/s11605-012-2069-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The main outcome parameters in oesophageal surgery have traditionally been morbidity and mortality, but quality of life (QL) has become an important consideration in view of the severity and persistence of postoperative symptoms. The aim of this study was to analyse QL before and after oesophagectomy for oesophageal cancer and to explore possible association with patient's and disease characteristics. One hundred twenty-six consecutive patients presenting with oesophageal cancer to the Oncological Surgery Unit of the Veneto Institute of Oncology between 2009 and 2011 were enrolled in this prospective study. The patients were asked to answer three QL questionnaires (the Italian versions of the QLQ-C30, the QLQ-OES18, and the IN-PATSAT32 modules developed by the European Organization for Research and Treatment of Cancer) at the time of disease diagnosis, after neoadjuvant therapy, immediately after surgery and at 1, 3, 6 and 12 months postoperatively. Global quality of life (QL2 item) seemed to improve after neoadjuvant therapy but it dropped markedly after surgery. It then rose to a value in between the one registered after neoadjuvant therapy and the one at diagnosis. Emotional function and dysphagia were associated to QL2 at diagnosis. After neoadjuvant therapy, age, oesophageal stenosis, emotional function and dysphagia were associated to good quality of life at that stage. After surgery, pain was associated to quality of life at that stage. During the early follow-up phase (1-3 months after surgery), role function and postoperative urinary complications were associated to QL2. In the long-term follow-up (6-12 months), adjuvant therapy, eating disorders and postoperative complications were associated to poor quality of life. Postoperative complications are associated to long-term emotional and physical function impairment which can lead to a significantly impaired global quality of life. Postoperative pain relief plays a key role in achieving a good postoperative quality of life. Finally, HRQL after oesophagectomy seems to be a function of therapeutic efficacy rather than of the specific surgical procedure used.
引用
收藏
页码:421 / 432
页数:12
相关论文
共 39 条
  • [1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    AHMEDZAI, S
    BERGMAN, B
    BULLINGER, M
    CULL, A
    DUEZ, NJ
    FILIBERTI, A
    FLECHTNER, H
    FLEISHMAN, SB
    DEHAES, JCJM
    KAASA, S
    KLEE, M
    OSOBA, D
    RAZAVI, D
    ROFE, PB
    SCHRAUB, S
    SNEEUW, K
    SULLIVAN, M
    TAKEDA, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
  • [2] Prospective, randomized, controlled trial of thoracic epidural or patient-controlled opiate analgesia on perioperative quality of life
    Ali, M.
    Winter, D. C.
    Hanly, A. M.
    O'Hagan, C.
    Keaveny, J.
    Broe, P.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2010, 104 (03) : 292 - 297
  • [3] Ancona E, 2001, CANCER, V91, P2165, DOI 10.1002/1097-0142(20010601)91:11<2165::AID-CNCR1245>3.0.CO
  • [4] 2-H
  • [5] Evaluation of the EORTC QLQ-C30 questionnaire: A comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients
    Apolone, G
    Filiberti, A
    Cifani, S
    Ruggiata, R
    Mosconi, P
    [J]. ANNALS OF ONCOLOGY, 1998, 9 (05) : 549 - 557
  • [6] PROSPECTIVE COMPARISON OF SURGERY ALONE AND CHEMORADIOTHERAPY WITH SELECTIVE SURGERY IN RESECTABLE SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS
    Ariga, Hisanori
    Nemoto, Kenji
    Miyazaki, Shukichi
    Yoshioka, Takashi
    Ogawa, Yohishiro
    Sakayauchi, Toru
    Jingu, Keiichi
    Miyata, Go
    Onodera, Ko
    Ichikawa, Hirofumi
    Kamei, Takashi
    Kato, Shunsuke
    Ishioka, Chikashi
    Satomi, Susumu
    Yamada, Shogo
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (02): : 348 - 356
  • [7] Quality of life during potentially curative treatment for locally advanced oesophageal cancer
    Avery, K. N. L.
    Metcalfe, C.
    Barham, C. P.
    Alderson, D.
    Falk, S. J.
    Blazeby, J. M.
    [J]. BRITISH JOURNAL OF SURGERY, 2007, 94 (11) : 1369 - 1376
  • [8] Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy
    Barbour, A. P.
    Lagergren, P.
    Hughes, R.
    Alderson, D.
    Barham, C. P.
    Blazeby, J. M.
    [J]. BRITISH JOURNAL OF SURGERY, 2008, 95 (01) : 80 - 84
  • [9] Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer
    Blazeby, JM
    Conroy, T
    Hammerlid, E
    Fayers, P
    Sezer, O
    Koller, M
    Arraras, J
    Bottomley, A
    Vickery, CW
    Etienne, PL
    Alderson, D
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (10) : 1384 - 1394
  • [10] Determinants of patient satisfaction in oncology settings from European and Asian countries:: Preliminary results based on the EORTC IN-PATSAT32 questionnaire
    Bredart, A.
    Coens, C.
    Aaronson, N.
    Chie, W. -C.
    Efficace, F.
    Conroy, T.
    Blazeby, J. M.
    Hammerlid, E.
    Costantini, M.
    Joly, F.
    Schraub, S.
    Sezer, O.
    Arraras, J. I.
    Rodary, C.
    Costantini, A.
    Mehlitz, M.
    Razavi, D.
    Bottomley, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2007, 43 (02) : 323 - 330